10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          Ketone bodies, mainly β-hydroxybutyrate and acetoacetate, are important alternative energy sources in a state of energy deficit or metabolic crisis. The consumption of ketogenic diets, such as low-carbohydrate and medium-chain triglyceride diets, and time-restricted feeding lead to ketogenesis, which influences longevity and health. β-Hydroxybutyrate also acts as a signaling molecule via GPR109A and GPR41; however, to date, the specific G protein-coupled receptors responsible for acetoacetate and its physiological functions remain unknown. In this study, we demonstrate that acetoacetate acts as an endogenous agonist of GPR43 by ligand screening in a heterologous expression system, and that it, rather than short-chain fatty acids, maintains energy homeostasis via GPR43-mediated lipid metabolism under ketogenic conditions.

          Abstract

          Ketone bodies, including β-hydroxybutyrate and acetoacetate, are important alternative energy sources during energy shortage. β-Hydroxybutyrate also acts as a signaling molecule via specific G protein-coupled receptors (GPCRs); however, the specific associated GPCRs and physiological functions of acetoacetate remain unknown. Here we identified acetoacetate as an endogenous agonist for short-chain fatty acid (SCFA) receptor GPR43 by ligand screening in a heterologous expression system. Under ketogenic conditions, such as starvation and low-carbohydrate diets, plasma acetoacetate levels increased markedly, whereas plasma and cecal SCFA levels decreased dramatically, along with an altered gut microbiota composition. In addition, Gpr43-deficient mice showed reduced weight loss and suppressed plasma lipoprotein lipase activity during fasting and eucaloric ketogenic diet feeding. Moreover, Gpr43-deficient mice exhibited minimal weight decrease after intermittent fasting. These observations provide insight into the role of ketone bodies in energy metabolism under shifts in nutrition and may contribute to the development of preventive medicine via diet and foods.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.

          Short chain fatty acids (SCFAs), including acetate, propionate, and butyrate, are produced at high concentration by bacteria in the gut and subsequently released in the bloodstream. Basal acetate concentrations in the blood (about 100 microm) can further increase to millimolar concentrations following alcohol intake. It was known previously that SCFAs can activate leukocytes, particularly neutrophils. In the present work, we have identified two previously orphan G protein-coupled receptors, GPR41 and GPR43, as receptors for SCFAs. Propionate was the most potent agonist for both GPR41 and GPR43. Acetate was more selective for GPR43, whereas butyrate and isobutyrate were more active on GPR41. The two receptors were coupled to inositol 1,4,5-trisphosphate formation, intracellular Ca2+ release, ERK1/2 activation, and inhibition of cAMP accumulation. They exhibited, however, a differential coupling to G proteins; GPR41 coupled exclusively though the Pertussis toxin-sensitive Gi/o family, whereas GPR43 displayed a dual coupling through Gi/o and Pertussis toxin-insensitive Gq protein families. The broad expression profile of GPR41 in a number of tissues does not allow us to infer clear hypotheses regarding its biological functions. In contrast, the highly selective expression of GPR43 in leukocytes, particularly polymorphonuclear cells, suggests a role in the recruitment of these cell populations toward sites of bacterial infection. The pharmacology of GPR43 matches indeed the effects of SCFAs on neutrophils, in terms of intracellular Ca2+ release and chemotaxis. Such a neutrophil-specific SCFA receptor is potentially involved in the development of a variety of diseases characterized by either excessive or inefficient neutrophil recruitment and activation, such as inflammatory bowel diseases or alcoholism-associated immune depression. GPR43 might therefore constitute a target allowing us to modulate immune responses in these pathological situations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41).

            The maintenance of energy homeostasis is essential for life, and its dysregulation leads to a variety of metabolic disorders. Under a fed condition, mammals use glucose as the main metabolic fuel, and short-chain fatty acids (SCFAs) produced by the colonic bacterial fermentation of dietary fiber also contribute a significant proportion of daily energy requirement. Under ketogenic conditions such as starvation and diabetes, ketone bodies produced in the liver from fatty acids are used as the main energy sources. To balance energy intake, dietary excess and starvation trigger an increase or a decrease in energy expenditure, respectively, by regulating the activity of the sympathetic nervous system (SNS). The regulation of metabolic homeostasis by glucose is well recognized; however, the roles of SCFAs and ketone bodies in maintaining energy balance remain unclear. Here, we show that SCFAs and ketone bodies directly regulate SNS activity via GPR41, a Gi/o protein-coupled receptor for SCFAs, at the level of the sympathetic ganglion. GPR41 was most abundantly expressed in sympathetic ganglia in mouse and humans. SCFA propionate promoted sympathetic outflow via GPR41. On the other hand, a ketone body, β-hydroxybutyrate, produced during starvation or diabetes, suppressed SNS activity by antagonizing GPR41. Pharmacological and siRNA experiments indicated that GPR41-mediated activation of sympathetic neurons involves Gβγ-PLCβ-MAPK signaling. Sympathetic regulation by SCFAs and ketone bodies correlated well with their respective effects on energy consumption. These findings establish that SCFAs and ketone bodies directly regulate GPR41-mediated SNS activity and thereby control body energy expenditure in maintaining metabolic homeostasis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Free Fatty Acid Receptors in Health and Disease

              Fatty acids are metabolized and synthesized as energy substrates during biological responses. Long- and medium-chain fatty acids derived mainly from dietary triglycerides, and short-chain fatty acids (SCFAs) produced by gut microbial fermentation of the otherwise indigestible dietary fiber, constitute the major sources of free fatty acids (FFAs) in the metabolic network. Recently, increasing evidence indicates that FFAs serve not only as energy sources but also as natural ligands for a group of orphan G protein-coupled receptors (GPCRs) termed free fatty acid receptors (FFARs), essentially intertwining metabolism and immunity in multiple ways, such as via inflammation regulation and secretion of peptide hormones. To date, several FFARs that are activated by the FFAs of various chain lengths have been identified and characterized. In particular, FFAR1 (GPR40) and FFAR4 (GPR120) are activated by long-chain saturated and unsaturated fatty acids, while FFAR3 (GPR41) and FFAR2 (GPR43) are activated by SCFAs, mainly acetate, butyrate, and propionate. In this review, we discuss the recent reports on the key physiological functions of the FFAR-mediated signaling transduction pathways in the regulation of metabolism and immune responses. We also attempt to reveal future research opportunities for developing therapeutics for metabolic and immune disorders.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                19 November 2019
                4 November 2019
                4 November 2019
                : 116
                : 47
                : 23813-23821
                Affiliations
                [1] aDepartment of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology , Fuchu-shi, 183-8509 Tokyo, Japan;
                [2] bJapan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development , Chiyoda-ku, 100-0004 Tokyo, Japan;
                [3] cDepartment of Endocrinology, Metabolism, and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center , 612-8555 Kyoto, Japan;
                [4] dDepartment of Endocrinology, Metabolism, and Nephrology, School of Medicine, Keio University , Shinjuku-ku, 160-8582 Tokyo, Japan;
                [5] eDepartment of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University , 606-8501 Kyoto, Japan
                Author notes
                2To whom correspondence should be addressed. Email: ikimura@ 123456cc.tuat.ac.jp .

                Edited by Robert J. Lefkowitz, HHMI and Duke University Medical Center, Durham, NC, and approved October 15, 2019 (received for review July 21, 2019)

                Author contributions: I.K. designed research; J.M., R.O.-K., H.M., A.N., K.W., and M.I. performed research; G.T. and I.K. contributed new reagents/analytic tools; J.M., R.O.-K., K.W., J.I., G.T., N.S.-A., H.I., and I.K. analyzed data; and J.M., R.O.-K., M.I., and I.K. wrote the paper.

                1J.M. and R.O.-K. contributed equally to this work.

                Author information
                http://orcid.org/0000-0003-2662-4121
                http://orcid.org/0000-0001-8778-145X
                Article
                201912573
                10.1073/pnas.1912573116
                6876247
                31685604
                6597e070-5ec2-43a1-8adb-beb0450185fc
                Copyright © 2019 the Author(s). Published by PNAS.

                This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

                History
                Page count
                Pages: 9
                Funding
                Funded by: MEXT | Japan Society for the Promotion of Science (JSPS) 501100001691
                Award ID: JP15H05344
                Award Recipient : Junki Miyamoto Award Recipient : Ikuo Kimura
                Funded by: MEXT | Japan Society for the Promotion of Science (JSPS) 501100001691
                Award ID: JP16H01355
                Award Recipient : Junki Miyamoto Award Recipient : Ikuo Kimura
                Funded by: MEXT | Japan Society for the Promotion of Science (JSPS) 501100001691
                Award ID: JP18K19731
                Award Recipient : Junki Miyamoto Award Recipient : Ikuo Kimura
                Funded by: MEXT | Japan Society for the Promotion of Science (JSPS) 501100001691
                Award ID: JP18K17920
                Award Recipient : Junki Miyamoto Award Recipient : Ikuo Kimura
                Funded by: Japan Agency for Medical Research and Development (AMED) 100009619
                Award ID: JP17gm1010007
                Award Recipient : Ikuo Kimura
                Categories
                Biological Sciences
                Physiology

                ketone body,fasting,low carbohydrate,gut microbiota,ffar2
                ketone body, fasting, low carbohydrate, gut microbiota, ffar2

                Comments

                Comment on this article